(Q35604818)

9 August 2017

1 reference

title

Advancing the field of drug delivery: taking aim at cancer (English)

1 reference

9 August 2017

1 reference

Robert S. Langer, Jr.

series ordinal

3

object named as

Robert Langer

1 reference

9 August 2017

1

Marsha A Moses

1 reference

9 August 2017

2

Henry Brem

1 reference

9 August 2017

publication date

1 November 2003

1 reference

9 August 2017

number of pages

5

1 reference

inferred from page(s)

published in

Cancer Cell

1 reference

9 August 2017

volume

4

1 reference

9 August 2017

issue

5

1 reference

9 August 2017

page(s)

337-341

1 reference

Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900276-9

7 January 2021

A new extra long acting depot preparation of the LHRH analogue Zoladex. First endocrinological and pharmacokinetic data in patients with advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900276-9

7 January 2021

The dawning era of polymer therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900276-9

7 January 2021

Local delivery of chemotherapy prolongs survival in experimental brain metastases from breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900276-9

7 January 2021

Structural and functional uncoupling of the enzymatic and angiogenic inhibitory activities of tissue inhibitor of metalloproteinase-2 (TIMP-2): loop 6 is a novel angiogenesis inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900276-9

7 January 2021

Nicotine medications for smoking cessation

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900276-9

7 January 2021

Transport of molecules, particles, and cells in solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900276-9

7 January 2021

Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900276-9

7 January 2021

Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900276-9

7 January 2021

Polymers for the sustained release of proteins and other macromolecules

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900276-9

7 January 2021

Isolations of a cartilage factor that inhibits tumor neovascularization

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900276-9

7 January 2021

Gliadel for pituitary adenomas and craniopharyngiomas

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900276-9

7 January 2021

Antiangiogenesis drug promising for metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900276-9

7 January 2021

Inhibitors of angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900276-9

7 January 2021

Troponin I is present in human cartilage and inhibits angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900276-9

7 January 2021

A new technique to efficiently entrap leuprolide acetate into microcapsules of polylactic acid or copoly(lactic/glycolic) acid

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900276-9

7 January 2021

One- and three-month release injectable microspheres of the LH-RH superagonist leuprorelin acetate

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900276-9

7 January 2021

Vaginal absorption of a potent luteinizing hormone-releasing hormone analog (leuprolide) in rats I: absorption by various routes and absorption enhancement.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900276-9

7 January 2021

Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900276-9

7 January 2021

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900276-9

7 January 2021

New challenges in biomaterials

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900276-9

7 January 2021

A controlled-release microchip

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900276-9

7 January 2021

An eight-month clinical study of LA-2575 30.0 mg: a new 4-month, subcutaneous delivery system for leuprolide acetate in the treatment of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900276-9

7 January 2021

Interstitial chemotherapy with carmustine-loaded polymers for high-grade gliomas: a randomized double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900276-9

7 January 2021

The role of minocycline in the treatment of intracranial 9L glioma.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900276-9

7 January 2021

A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2803%2900276-9

7 January 2021

10.1016/S1535-6108(03)00276-9

Identifiers

DOI

1 reference

9 August 2017

1 reference